HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • RECORDED WEBINAR: Understanding SDS Risk Adjustment and Why the Window for Health Plan Action Is Now
  • Single-Specialty Nephrology Networks: A Distinct Advantage in Value-Based | VBCEH Exclusive
  • Why value-based care and quality go hand in hand
  • Flawed Benchmark Policy Taxes Accountable Care’s Most Successful Providers
  • Expanding Medicare’s joint replacement model: Considerations for healthcare providers regarding the new CJR-X Model | Milliman MedInsight
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us